astemizole and l 706000

astemizole has been researched along with l 706000 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L	1
Contreras-Jurado, C; Furini, S; García-Ferreiro, R; Gómez-Varela, D; Pardo, LA; Stühmer, W	1

Other Studies

2 other study(ies) available for astemizole and l 706000

Article	Year
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation. European journal of medicinal chemistry, 2008, Volume: 43, Issue:11 Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG	2008
Different relevance of inactivation and F468 residue in the mechanisms of hEag1 channel blockage by astemizole, imipramine and dofetilide. FEBS letters, 2006, Sep-18, Volume: 580, Issue:21 Topics: Astemizole; Benzopyrans; Ether-A-Go-Go Potassium Channels; Humans; Imipramine; Ion Channel Gating; Models, Molecular; Phenethylamines; Piperidines; Point Mutation; Potassium Channel Blockers; Structure-Activity Relationship; Sulfonamides	2006

Article

Year

Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.

European journal of medicinal chemistry, 2008, Volume: 43, Issue:11

Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG

2008

Different relevance of inactivation and F468 residue in the mechanisms of hEag1 channel blockage by astemizole, imipramine and dofetilide.

FEBS letters, 2006, Sep-18, Volume: 580, Issue:21

Topics: Astemizole; Benzopyrans; Ether-A-Go-Go Potassium Channels; Humans; Imipramine; Ion Channel Gating; Models, Molecular; Phenethylamines; Piperidines; Point Mutation; Potassium Channel Blockers; Structure-Activity Relationship; Sulfonamides

2006